Immunization & Vaccine Information for Health Professionals
The Ontario Government Pharmaceutical and Medical Supply Services (OGPMSS) will be closed from March 18 to April 1, 2019, for their year-end inventory. During this time, orders cannot be processed.
To meet your operational needs during the temporary shutdown period, please order sufficient supplies by March 15, 2019.
Vaccine orders from Toronto Public Health for high-risk clients or students will be accepted, but will not be delivered until after April 2, 2019.
Please read the information on eligibility criteria first.
Stay current on changes:
- Limited Supply of Shingles Vaccine – March 7, 2019
- Hepatitis A Vaccine Supply – February 20, 2019
- Td POLIO (Td-IPV) Vaccine is No Longer Available – November 26, 2018
- Changes to OGPMSS Delivery Schedule for Toronto Health Care Providers – October 2018
- Rotavirus Vaccine Product Change – August 21, 2018
- National Advisory Committee on Immunization (NACI) Recommendation on Herpes Zoster Vaccines – June 20, 2018
- Reporting Requirements for Immunizations – June 18, 2018
- Leaking vaccine syringe – Potential Risk of Underdosing – May 3, 2018
- New Guidelines from NACI: Pertussis Vaccination in Pregnancy – March 7, 2018
Approaches to vaccine hesitancy
- Be non-judgemental.
- Be presumptive that a child will be vaccinated.
- Never dismiss a child from practice.
- Set aside time to counsel parents.
- Use every visit as an opportunity to discuss vaccines.
- Validate parental concerns and correct misconceptions.
- Discuss the benefits and risk of vaccines versus risk of diseases.
- Frame data clearly and positively.
Adapted with permission from the Canadian Paediatric Society: Working with Vaccine-Hesitant Parents: An Update September 14, 2018.
Health care practitioners are required to report AEFIs to Toronto Public Health. You can also report by calling our immunization nurses 416-338-2030.
- AEFI Fact Sheet (Public Health Ontario)
- AEFI Reporting Form (Public Health Ontario)
- More information on AEFIs
If the form does not open in the browser, use a different browser or download and save it before completing.
Vaccines can lose their effectiveness when exposed to light or temperatures outside +2°C and +8°C range. Please review the Vaccine Storage and Handling Guidelines to ensure vaccine potency and reduce wastage.
Your patients look to you for trusted advice
- Be positive.
- Listen to your client’s concerns.
- Refute misinformation.
- Encourage clients to seek credible sources for more information.
- Integrate adult vaccination into your primary care.
- Address waning immunity in diseases more common to adults.
- Assess client risks based on their occupation, travel habits, underlying illness, lifestyle and/or age.
- Vaccines for adults may not prevent the onset of disease, but will at least reduce disease severity.
- Influenza Vaccine Supply Update for Toronto – January 28, 2019
- Influenza Vaccines Shipments to Toronto Doctors – October 16, 2018
- Recommended Influenza Vaccine for Adults, 65+ – October 10, 2018
- 2018/2019 Universal Influenza Immunization Program (UIIP) Update – September 20, 2018
- Influenza Reporting, Surveillance and Updates
Influenza vaccination in pregnancy is safe and effective in protecting mother and baby.
The National Advisory Committee on Immunization (NACI) and other expert advisories have been recommending influenza vaccination for pregnant women for many years. It is therefore considered the standard of care for pregnant women.
Note: The live attenuated influenza vaccine is contraindicated in pregnancy.
Benefits of vaccination in pregnancy
- It protects pregnant women from hospitalizations as a result of influenza infection.
- Infants are less likely to be born premature or with low birth weight.
- It protects the baby from influenza in the first few months of life because the vaccinated pregnant woman passes antibodies to the baby during pregnancy.